What is the recommended tapering schedule for discontinuing 100mg of Seroquel (quetiapine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Quetiapine (Seroquel) 100mg

For quetiapine 100mg, reduce the dose by 25mg every 2 weeks until reaching 25mg, then consider switching to 25mg every other day for 2 weeks before discontinuation. 1

Recommended Tapering Schedule

Gradual dose reduction over 6-8 weeks minimizes withdrawal symptoms and prevents symptom relapse. 1, 2

Specific Tapering Protocol:

  • Week 1-2: Reduce from 100mg to 75mg daily 1
  • Week 3-4: Reduce from 75mg to 50mg daily 1
  • Week 5-6: Reduce from 50mg to 25mg daily 1
  • Week 7-8: Take 25mg every other day for 2 weeks 1
  • Week 9: Discontinue completely 1

This schedule represents a 25mg reduction every 2 weeks, which is appropriate for the relatively low starting dose of 100mg. 1

Critical Monitoring Requirements

Schedule follow-up appointments every 2-4 weeks during the taper to assess for withdrawal symptoms and symptom recurrence. 2

Watch for Withdrawal Symptoms:

  • Insomnia, anxiety, irritability, nausea, dizziness, and headache are common withdrawal symptoms. 1, 3
  • If withdrawal symptoms occur, return to the previous well-tolerated dose and slow the taper further. 1, 2
  • Consider adjunctive medications for specific withdrawal symptoms (e.g., trazodone for insomnia). 1

Monitor for Symptom Relapse:

  • Document baseline symptoms before initiating the taper to identify any return of original psychiatric symptoms. 2
  • Patients with psychiatric disorders may experience symptom return weeks to months after dose reduction. 2
  • If original symptoms return, consider temporarily returning to the previous dose before attempting a smaller reduction (e.g., 12.5mg decrements). 2

Important Contraindications to Rapid Tapering

Abrupt discontinuation of quetiapine is considered unacceptable medical care and can trigger significant withdrawal symptoms. 2

  • Never stop quetiapine suddenly—this can cause severe withdrawal and symptom rebound. 2
  • Patients on long-term therapy (months to years) require slower tapers than those on short-term treatment. 1, 3
  • If the patient has been on 100mg for an extended period, consider extending each dose reduction interval to 4 weeks instead of 2 weeks. 1

Managing Complications During Tapering

If severe withdrawal symptoms develop, immediately return to the previous dose and implement a more gradual taper with smaller dose reductions (12.5mg instead of 25mg). 1, 2

Adjusting the Taper:

  • For patients who cannot tolerate 25mg reductions, use 12.5mg reductions every 2-4 weeks. 2
  • Extend the time between dose reductions to 4-6 weeks if needed. 2
  • Each new dose should be maintained until the patient is stable before proceeding to the next reduction. 1

Special Considerations

Quetiapine has a relatively short half-life of approximately 7 hours, which may contribute to withdrawal symptoms if tapered too quickly. 4

  • The sedating effects of quetiapine mean withdrawal insomnia is particularly common. 1
  • Quetiapine's low propensity for extrapyramidal symptoms means withdrawal movement disorders are unlikely. 5, 6
  • Avoid "cold referrals" to other clinicians during the taper—maintain continuity of care throughout the discontinuation process. 2

Common Pitfalls to Avoid

  • Do not taper faster than 25mg every 2 weeks for a 100mg starting dose. 1
  • Do not skip the "every other day" dosing phase before complete discontinuation. 1
  • Do not discontinue follow-up appointments prematurely—symptoms may emerge weeks after the final dose. 2
  • Do not ignore early withdrawal symptoms hoping they will resolve—they typically worsen without intervention. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Risperidone Tapering Schedule

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Citalopram Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Review of quetiapine and its clinical applications in schizophrenia.

Expert opinion on pharmacotherapy, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.